Member Info for Moneymunch

The Quest for Extended Youth

Bar-Ilan University to host four-day international conference exploring the future of healthy longevity

Newswise — Later this month Bar-Ilan University will host an international conference dedicated to the advancement of research, development and education in the field of healthy longevity. The conference, entitled “Longevity Nation 2024 – Enhancing Research, Development and Education for Healthy Longevity”, will bring together leading voices in longevity research from around the world. It will take place from October 28-31 on the Bar-Ilan University campus in Ramat Gan, Israel.

.......

Notable speakers will include:

Prof. Haim Cohen (Goodman Faculty of Life Sciences, Bar-Ilan University), who is researching the protein SIRT6. In his lab, mice engineered to produce extra SIRT6 don't just live longer – they stay healthier for longer, too. Cohen's research is shedding light on how SIRT6 helps maintain healthy aging, particularly by providing the required energy at old age and slowing aging-related frailty. This work could pave the way for new therapies that boost SIRT6 activity in humans.

Repurposing Old Drugs for New Tricks

Dr. Nir Barzilai (Albert Einstein College of Medicine) focuses on repurposing existing FDA-approved drugs for their potential anti-aging properties. One example is the diabetes drug metformin, which has been shown to provide broader health benefits, and potentially slowing the aging process itself.

htTps://www.newswise.com/articles/the-quest-for-extended-youth

.........

Dr Nir Barzilai is also a partner n Genflow's key European Patent. Gl :-)

hTtps://einsteinmed.edu/faculty/484/nir-barzilai

21 March 2024

Genflow Biosciences Plc

Announces Publication of a Key European Patent in Partnership with University of Rochester, New York, et al.

Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the Company"), an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases, is pleased to announce a significant milestone in its journey. Genflow's collaborative partners, including the University of Rochester, The Trustees of Columbia University in the City of New York, and Albert Einstein College of Medicine, have received confirmation that their European patent application was published today by the European Patent Office, bearing the reference number EP 4 338 267.

Nice one Porter and Cheers!!! Thank you for the explanation on OTC and no need to worry about any adversity, I'm a seasoned campaigner. Gl :-)

Jeez Hikdik. what are you, some sort of wet nurse for your obnoxious mate, and wow he bought 200k shares, ha ha ha , so what, i'm holding 10 times all under 1.8p ho ho ho.........now trot on and find something useful to do instead hanging around share forums you're not invested, and by the way no one was trying to mislead, it was observation of on a 52% rise on OTC and a recorded 2.2m plus trade.........Anyways, got a feeling we're ready to roll....Gla holders ;-)

NTL Ask Price 0.0423 Size 2,249,850 Time 10/08

https://www.otcmarkets.com/stock/GENFF/overview

What humans can learn from animals that age better than we do

Vera Gorbunova will share groundbreaking research on the biological mechanisms of aging at the Fralin Biomedical Research Institute at VTC’s next Maury Strauss Distinguished Public Lecture.

....

Gorbunova, a professor and co-director of the University of Rochester’s Aging Research Center, studies longevity and cancer resistance in mammals with extraordinary lifespans. Her lab studies long-lived mammals in hopes of creating interventions to prevent and treat age-related diseases in humans.

She will deliver a talk about the “Mechanisms of Longevity: From Mice to Whales” at the Fralin Biomedical Research Institute at VTC in Roanoke at 5:30 p.m. on Thursday, Oct. 10.

hTtps://news.vt.edu/articles/2024/10/research_fralinbiomed_gorbunovadpl_1007.html

Lol Porter, the less said the better, and we'll done on your holding here, and shouldn't be too long before the next UPdate or two to get the sp North!!! Gl :-)

Nice find Porter, and looking forward to some positive newsflow from Eric in the coming days. Gl :-)

Lol lile, are you for real, you sanctimonious oaf.

Ps Hikikompori, what's Genff's sp on OTC from the link you posted, please let me know? Gl :-)

Lol lile, get over yourself mate, no one misleading here apart from you, and only an observation from those invested here following a 52% rise on OTC following a recorded share volume ( trade ) of 2.2m plus. No idea why there would be such a move and you obviously have no idea you can share either. In the meantime, positive newsflow could drop at anytime, including more non-dilutive grant cash which us imminent!!! Gla holders:-)

Lol, so you can't explain the reason for the 52% rise...ho ho Gl :-)

https://www.bloomberg.com/quote/GENFF:US?embedded-checkout=true

So explain the 52% rise.

Lol lile, now don't get above yourself mate, initially it was an observation on a 52% rise, and as the Ask is usually the price a seller is willing to accept, as you're such a clever barsteward, why don't you explain the reason for the move??? Gl:-)

Lol lile, get your head into the sunshine mate!!! Gl. :-)))

GENFF

Genflow Biosciences Plc

Ordinary Shares

0.0423

0.0145

52.13%

0.02 / 0.0423 (10000 x 2249850)

Real-Time Best Bid & Ask: 11:51am 10/07/2024

Delayed (15 Min) Trade Data: 12:00am 10/03/2024

No apologies from me Porter and will continue to highlight Genflow's potential and prospects as I see fit. A 2.2m plus trade went through after hours ( c$44k and extremely encouraging imho ) on OTC and the sp closed 52% UP!!! Fact!!!! Anyways, with plenty of potential positive newsflow in the pipeline , it shouldn't be too long before a significant move North here imho.

Well, no idea how the OTC Market works, still showing 52% UP at $0.0423!!!??? Should be interesting what this coming week brings, potential positive newsflow, stacking UP on several fronts. Gla holders...in Eric we trust!!! :-)

Lol Lile, steady mate and why so hostile??? The regular posters here are optimistic about Genflow's prospects and we generally post factual info relevant to our investment. It was noted that Genff closed 52% up after close on the back of what looks like a $44k plus trade, and obviously that was going to stir excitement as we all hold substantial number of shares, and so before you go off spouting your sanctimonious diatribe , let's wait to see when the OTC reopens what happens. Multiple positive newsflow expected soon, and so not too long before this heads North imho!!! Gla holders :-)

It closed up 52% , so let's see where it opens at 1pm, very interesting move. Gl ;-)

Not at all, $44, 997 at 2 cents!!!??? Gl :-)

Boom.....52% UP!!!! Fingers crossed the UK will follow the US, and all eyes on the US OTC Markets when they open at 1pm as well as here at 8am...... Gla holders....On and UP!!!! ;-)

htTps://www.otcmarkets.com/stock/GENFF/overview

Wow, just tuned in and very exciting. Let's hope for a surge in US investor interest led by those in the know. Big news could drop at anytime , and plenty of positive newsflow expected soon. Gla holders:-)

Without doubt Porter, the one with Vera at University of Rochester is for Preventing and/or treating Age related diseases ( a long list of diseases) another is specifically focused on Liver/MASH but the third is for Invivo Administration and coding of Sirt6 through AAV delivery, which presumably covers all of studies and more. Gl :-)